Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer. Shimada T, Izumi K, Kano H, Kadomoto S, et al. Anticancer Res 2022;42:1065-1071.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shimada T, Izumi K, Kano H, Kadomoto S, et al. Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer. Anticancer Res 2022;42:1065-1071.
PMID: 35093908